Latest News
Phio Pharmaceuticals Corp.
- Phio Pharmaceuticals Corp. Estimates – NASDAQ:PHIO
- Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
- Phio Pharmaceuticals to present its INTASYL siR...
- Phio Pharmaceuticals Completes Commercial cGMP Batch of PH-762
- Phio Pharmaceuticals Announces Successful Completion of First Commercial-Scale cGMP Batch of PH-762 Drug Substance
- Phio Pharmaceuticals completes first commercial-scale PH-762 batch
- Phio Pharmaceuticals at Small Cap Growth Hybrid Investor Conference: cSCC push By Investing.com
- A cancer approach designed to help immune cells fight tumors is the focus of Phio's presentation.
- Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference
- Phio Pharmaceuticals to present cancer therapy updates at NIBA conference in October 2026
- PHIO Stock Slips to $0.98 as Phio Pharmaceuticals Holds Near Key Support - Cash Secured Put
- Phio Pharmaceuticals (PHIO) Slips 1.50% to $0.98, Testing Support Near $0.93 - PCR Mean Reversion
Headlines from the last 30 days, linking to the original publishers. See all market news →